🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigating the efficacy of Cetuximab Monotherapy versus Continuation aft...
Status
Unknown
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02978313
The pancreas cancer is the 4th cause of death. All stage confused, the surv...
Status
Completed
Location
CHU - Hôtel Dieu
Start Date
2015-01-12
Trial ID
NCT02352337
Treatments Being Tested
The main objective of this randomized trial is to compare 5FU/LV (Mayo-Clin...
Status
Unknown
Location
AERO
Start Date
TBD
Trial ID
NCT00189657
Treatments Being Tested
Colorectal cancer is the 3rd most common cancer in France and the 2nd cause...
Status
Recruiting
Location
Hôpital Erasme
Start Date
2016-12
Trial ID
NCT02885753
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Institut Bergonie
Start Date
2007-01-23
Trial ID
NCT00467142
Treatments Being Tested
The goal of this clinical trial is to estimate the antitumor response of mF...
Status
Recruiting
Location
Marseille CRLCC
Start Date
2025-02-18
Trial ID
NCT06757244
Treatments Being Tested
The intensity of tumour response appears to be correlated with the feasibil...
Status
Terminated
Location
Hopital Pierre Oudot - Service de Gastroenterologie
Start Date
2016-09
Trial ID
NCT02842580
Treatments Being Tested
In first-line metastatic colorectal cancer (mCRC), baseline prognostic fact...
Status
Terminated
Location
Centre Hospitalier Universitaire de Besançon
Start Date
2017-08-04
Trial ID
NCT03117972
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Centre Hospitalier de L' Agglomeration Montargoise
Start Date
2002-07-23
Trial ID
NCT00066274
The main objective of PANORAMIX phase II trial is to optimize first-lie (L1...
Status
Not Yet Recruiting
Location
CHU de Besançon
Start Date
2025-07
Trial ID
NCT07028424
Treatments Being Tested